These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 11273592)

  • 21. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
    Kelsen DP; Saltz L; Cohen AM; Yao TJ; Enker W; Tong W; Tao Y; Bertino JR
    Cancer; 1994 Oct; 74(8):2224-33. PubMed ID: 7922973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
    Kodaira S; Shatari T; Nozawa K
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2201-8. PubMed ID: 11142163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.
    Wolmark N; Rockette H; Fisher B; Wickerham DL; Redmond C; Fisher ER; Jones J; Mamounas EP; Ore L; Petrelli NJ
    J Clin Oncol; 1993 Oct; 11(10):1879-87. PubMed ID: 8410113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU/LV) and FU/LV plus oxaliplatin.
    Yothers G; O'Connell MJ; Lee M; Lopatin M; Clark-Langone KM; Millward C; Paik S; Sharif S; Shak S; Wolmark N
    J Clin Oncol; 2013 Dec; 31(36):4512-9. PubMed ID: 24220557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01.
    Wolmark N; Fisher B; Rockette H; Redmond C; Wickerham DL; Fisher ER; Jones J; Glass A; Lerner H; Lawrence W
    J Natl Cancer Inst; 1988 Mar; 80(1):30-6. PubMed ID: 3276901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Progression of adjuvant chemotherapy for colon cancer].
    He YJ; Dong QM; Li YH
    Ai Zheng; 2005 Dec; 24(12):1546-9. PubMed ID: 16351811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.
    Pandor A; Eggington S; Paisley S; Tappenden P; Sutcliffe P
    Health Technol Assess; 2006 Nov; 10(41):iii-iv, xi-xiv, 1-185. PubMed ID: 17049138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant therapy for colon adenocarcinoma: current status of clinical investigation.
    Köhne-Wömpner CH; Schöffski P; Schmoll HJ
    Ann Oncol; 1994; 5 Suppl 3():97-104. PubMed ID: 8204538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer.
    Hong KD; Lee SI; Moon HY
    Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UFT/leucovorin vs 5-FU/leucovorin in colon cancer.
    Smith RE; Lembersky BC; Wieand HS; Colangelo L; Mamounas EP
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):24-7. PubMed ID: 11098486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The addition of low-dose leucovorin to the combination of 5-fluorouracil- levamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer. IKN Colon Trial Group.
    Bleeker WA; Mulder NH; Hermans J; Otter R; Plukker JT
    Ann Oncol; 2000 May; 11(5):547-52. PubMed ID: 10907947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06.
    Kopec JA; Yothers G; Ganz PA; Land SR; Cecchini RS; Wieand HS; Lembersky BC; Wolmark N
    J Clin Oncol; 2007 Feb; 25(4):424-30. PubMed ID: 17264338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.
    André T; Quinaux E; Louvet C; Colin P; Gamelin E; Bouche O; Achille E; Piedbois P; Tubiana-Mathieu N; Boutan-Laroze A; Flesch M; Lledo G; Raoul Y; Debrix I; Buyse M; de Gramont A
    J Clin Oncol; 2007 Aug; 25(24):3732-8. PubMed ID: 17704423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
    Saltz LB; Niedzwiecki D; Hollis D; Goldberg RM; Hantel A; Thomas JP; Fields AL; Mayer RJ
    J Clin Oncol; 2007 Aug; 25(23):3456-61. PubMed ID: 17687149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An overview of adjuvant systemic chemotherapy for colon cancer.
    Andre T; de Gramont A;
    Clin Colorectal Cancer; 2004 Jun; 4 Suppl 1():S22-8. PubMed ID: 15212702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. North Central Cancer Treatment Group--Mayo Clinic trials in colon cancer.
    O'Connell MJ
    Semin Oncol; 2001 Feb; 28(1 Suppl 1):4-8. PubMed ID: 11273589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.
    Sobrero A; Frassineti G; Falcone A; Dogliotti L; Rosso R; Di Costanzo F; Bruzzi P;
    Br J Cancer; 2005 Jan; 92(1):24-9. PubMed ID: 15611795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant therapy of colon cancer.
    Macdonald JS
    CA Cancer J Clin; 1999; 49(4):202-19. PubMed ID: 11198882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
    Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Papavramidis S; Bousoulegas A; Basdanis G; Giannoulis E; Dokmetzioglou J; Katsohis C; Nenopoulou E; Karvounis N; Briassoulis E; Aravantinos G; Kosmidis P; Skarlos D; Pavlidis N
    Oncology; 2000 Apr; 58(3):227-36. PubMed ID: 10765125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.